Together with Patients
Sumitomo Pharma Group conducts the business activities driven by its Mission "To broadly contribute to society through value creation based on innovative research and development activities for the betterment of healthcare and fuller lives of people worldwide."
In July 2023, we restructured our existing framework of philosophy and established a unified Philosophy for
the entire Sumitomo Pharma Group, including Values that all executives and employees should share. These
Values articulate the beliefs that we have cherished since the inception of the Company and have now
assimilated into our daily mindset, fostering alignment among all employees within our Group.
One of our Values is "Patient First," which emphasizes the significance of prioritizing the diverse
well-being of patients above all else.
Values (values that all executives and employees should share)
| Values | What we value |
|---|---|
| Patient First | We value above all the health of the patients we serve today and in the future. |
| Always with Integrity | We always approach our work with uncompromising sincerity, honesty and dignity. |
| One Diverse Team | We respect each other's individuality and value our combined strength as “One Team” with diversity. |
For more information on the Group's Philosophy, please see “Philosophy.”
Thoughts on Our Value ”Patient First”
- We prioritize contributing to health and outcomes above all else.
- We carefully consider what we can and should do to improve the health and quality of life of all people.
Sumitomo Pharma Group considers that a patient-first approach is important for new value creation such as development of innovative products and healthcare solutions.
We will contribute to the realization of healthier and fuller lives of patients. We will achieve this not only by creating new value, but also by actively working to provide high-quality information that meets the need of patients, and to further improve the society’s disease literacy through awareness-raising and patient advocacy.
Our Vision at Sumitomo Pharma as “Patient First”
To provide the greatest value for the betterment of healthcare and fuller lives of people worldwide, we
believe it is crucial to listen to the voices of patients, patient groups, their families, and supporters. We
aim to incorporate these voices into our activities such as pharmaceutical research, development, production,
quality management, sales, corporate regulatory compliance and quality assurance, and medical science.
Additionally, we will focus on social issues surrounding patients and their families, engage with society to
address these issues, and contribute to healthcare that supports people’s healthier and fuller lives.
To further promote our commitment to “Patient First” across the entire Company, we established a cross- departmental meeting in 2023, selecting “Patient First Ambassadors” from departments involved in collaborative efforts with patients. In this meeting we first developed guidelines to ensure a unified understanding across the whole organization on the mindset, considerations, and procedures for collaborating with patients. These guidelines have been published on the Company's intranet site "Collaboration with Patients and Patient Groups" to be widely known among the employees. Moving forward, we aim to build trust with patients and contribute to the delivery of better healthcare.
For more information on our activities for disease awareness-raising and patient advocacy, please see “Patient Support and Advocacy.”